Reaction
Haematopoietic Stem Cell Mobilisation reporting signals
As of the last recalculation, Haematopoietic Stem Cell Mobilisation appears in 63 FAERS reports alongside 5 co-occurring drug terms. The strongest observed disproportionality signal is BRENTUXIMAB VEDOTIN (PRR 691.0).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Brentuximab Vedotin | 16 | 691.0 | 692.0 |
| Gentamicin | 14 | 454.4 | 454.9 |
| Ifosfamide | 18 | 387.1 | 387.4 |
| Gentamicin Sulfate | 14 | 376.1 | 376.4 |
| Blinatumomab | 4 | 135.2 | 135.2 |